Prolonged SARS -CoV-2 Infection With Common Features in Two Patients Receiving Anti-CD20 Therapy.

Amalia Papanikolopoulou, Vasilis Thimis, Eirini Antonogiannaki,Vasiliki Rapti,Konstantinos Tsiakos, Giannis Krallis, Sofia Ntouraki,Georgios Kokkotis,Emmanouil Panagiotou,Vissaria Sakka,Eleni Kakalou,Thomas Nitsotolis,Garyphallia Poulakou,Konstantinos N Syrigos

In vivo (Athens, Greece)（2023）

引用 1|浏览13

暂无评分

摘要

These two cases highlight the risk for persistent SARS-CoV-2 infection in patients treated with anti-CD20 monoclonal antibodies and support a role for cellular immunity recovery for disease control.

查看译文

关键词

COVID-19,SARS-CoV-2,cellular immunity,chronic lymphocytic leukemia,obinutuzumab,rheumatoid arthritis,rituximab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要